期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 50, 期 -, 页码 154-162出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2012.01.050
关键词
Antiproliferative agents; Choline kinase inhibitors; Pyridinium compounds; Molecular modeling; Docking studies
资金
- Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia [P07-CTS-03210]
- Ministerio de Ciencia e Innovacion [SAF2009-11955]
- Ministerio de Educacion
Inhibition of Choline Kinase (ChoK) has been reported as a therapeutical target in the treatment of some kinds of tumor. In this paper, the design and synthesis of new non-symmetrical monocationic ChoK inhibitors is described, bearing a cationic head and an adenine moiety connected by linkers of different lengths. Docking studies indicate that the cationic head of these compounds could be inserted into the choline binding site of the enzyme, while the adenine moiety could be stabilized into the ATP binding site. Docking studies also support the difference of activity of the synthesized compounds, which depends on both the substituent at position 4 of the cationic head and the linker length, being dimethylamine and 1,4-diphenylbutane respectively, the most appropriate ones. Compounds 14 (IC50 = 10.70 +/- 0.40 mu M) and 17 (IC50 = 6.21 +/- 0.97 mu M) are the most potent ChoK inhibitors and suitable for further modification with a view to obtain more potent antitumor compounds. (C) 2012 Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据